Dermapharm Holding SE (DMPHF)
OTC Markets OTCPK · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$47.69 (+0.00%) as of
Key statistics
- Market cap
- 2.36B
- P/E (TTM)
- 14.76
- EPS (TTM)
- 3.23
- Dividend yield
- 2.11%
- 52-week range
- 39.56 – 53.00
- Beta
- 0.87
- Revenue (TTM)
- 1.18B
- Profit margin
- 12.39%
- Volume
- 100.00
About Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Grünwald, Germany
- Employees
- 3,619
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.